Compare NRIX & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | CCS |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | 357 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2020 | 2014 |
| Metric | NRIX | CCS |
|---|---|---|
| Price | $15.62 | $57.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $29.46 | ★ $70.50 |
| AVG Volume (30 Days) | ★ 690.4K | 216.2K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.98% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.86 |
| Revenue | $76,987,000.00 | ★ $4,117,816,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.32 | $10.84 |
| P/E Ratio | ★ N/A | $12.06 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.18 | $50.42 |
| 52 Week High | $22.50 | $76.00 |
| Indicator | NRIX | CCS |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 24.14 |
| Support Level | $15.62 | $56.72 |
| Resistance Level | $16.47 | $64.48 |
| Average True Range (ATR) | 0.80 | 2.12 |
| MACD | 0.09 | -1.31 |
| Stochastic Oscillator | 57.14 | 7.10 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.